Harvard Psychedelic-Assisted Psychotherapy: Neglected Clinical Complexities 2026
$67.5
$127.58
Harvard CME – Psychedelic-Assisted Psychotherapy Conference 2026 Videos PDFS 5th Annual Clinical Conference Dates: February 26–27, 2026 Format: Live Online or In Person Developed by: Harvard Medical School Teaching Hospitals Offered by: Cambridge Health Alliance Course Overview Explore the rapidly evolving field of psychedelic-assisted psychotherapy (PAP) at this 5th annual clinical conference. This program is designed to help clinicians navigate complex therapeutic situations, emerging research, and best practices in psychedelic therapy. Participants will gain deeper clinical insight through case studies, clinical vignettes, expert discussions, and panel sessions. The course focuses on helping both new and experienced clinicians understand the nuances of psychedelic therapy, including spiritual experiences, non-ordinary states of consciousness, and managing potential risks or adverse effects. The conference also provides updates on the latest scientific evidence, therapeutic frameworks, and multidisciplinary approaches used in PAP. What You Will Learn After completing this course, participants will be able to: Understand the core principles and structure of psychedelic-assisted psychotherapy (PAP) Identify commonly used medicines in PAP and their clinical applications Review the latest clinical evidence supporting PAP Recognize emotional states such as grief, awe, and transpersonal experiences during therapy Address spiritual, existential, and metaphysical aspects of psychedelic therapy Compare Western and Indigenous perspectives on non-ordinary states of consciousness Identify potential risks and adverse effects in PAP Apply strategies to minimize harm and improve patient safety Understand the role of multidisciplinary collaboration in psychedelic treatment Recognize common somatic experiences during psychedelic sessions Apply the non-directive therapeutic approach in psilocybin sessions Manage complex clinical encounters in psychedelic psychotherapy Who Should Attend This course is designed for healthcare professionals involved in mental health and psychotherapy, including: Psychiatrists Primary Care Physicians Psychologists Social Workers Counselors Nurses Mental Health Clinicians Researchers and other healthcare professionals Program Schedule Day 1 – Thursday, February 26, 2026 Key sessions include: Back to Basics: The Method and the Medicines of PAP Clinical Outcomes of Psychedelic Therapy Neglected Considerations for Set & Settings Somatic Experiences in Psychedelic Therapy Religious and Spiritual Perspectives in PAP Panel discussions and case-based learning Day 2 – Friday, February 27, 2026 Highlights include: Western vs Indigenous Approaches to Psychedelic Experiences Ego Dissolution Case Studies Managing Difficult or Adverse Psychedelic Experiences Psychedelic-Boosted Behavioral Therapy for OCD Interdisciplinary Collaboration in PAP Clinical Complexities in Psychedelic Therapy
Neurology